Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay Kilburn, Dong-anh Khuong Quang, Jordan Hansford, Daniel Landi, Jasper Van Der Lugt, Sarah E Leary, Pablo Driever, Simon Bailey, Sébastien Perreault, Geoffrey Mccowage, Angela Waanders, David Ziegler, Olaf Witt, Patricia Baxter, Hyoung Kang, Timothy Hassall, Jung Han, Darren Hargrave, Andrea Franson, Michal Yalon Oren, Helen Toledano, Valérie Larouche, Cassie Kline, Mohamed Abdelbaki, Nada Jabado, Nicholas Gottardo, Nicolas Gerber, Nicholas Whipple, Devorah Segal, Susan Chi, Liat Oren, Enrica E Tan, Sabine Mueller, Izzy Cornelio, Lisa Mcleod, Xin Zhao, Ashley Walter, Daniel Da Costa, Peter Manley, Samuel Blackman, Roger Packer, Karsten Nysom